4.1 Article

Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results

Summary: The authors of the study reported the interim results of using four repurposed antiviral drugs (remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a) in hospitalized COVID-19 patients. The study showed that these drug regimens had little or no effect on overall mortality, initiation of ventilation, and duration of hospital stay.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

Peter Chen et al.

Summary: LY-CoV555, a neutralizing antibody, showed promising results in reducing viral load, improving symptoms, and lowering the risk of hospitalization among patients with mild or moderate Covid-19. While one of the doses appeared to accelerate the decline in viral load, others did not show significant effects by day 11.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Multidisciplinary Sciences

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19

Tyler N. Starr et al.

Summary: Research has found that mutations in the receptor binding domain (RBD) of SARS-CoV-2 may potentially escape the action of the REGN-COV2 cocktail, providing important information for interpreting mutations observed during viral surveillance.

SCIENCE (2021)

Article Multidisciplinary Sciences

Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape

Kevin R. McCarthy et al.

Summary: The translation above discusses zoonotic pandemics caused by animal viruses spilling over into highly susceptible human populations, specifically focusing on the evolution of coronaviruses in human hosts and the impact of recurrent deletions in the spike glycoprotein on antibody epitopes. These studies help understand the antigenic evolution and adaptive evolution of SARS-CoV-2.

SCIENCE (2021)

Article Biochemistry & Molecular Biology

Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication

Jack P. K. Bravo et al.

Summary: Remdesivir, a nucleoside analog approved by the US FDA for treating COVID-19, was found to delay chain termination by blocking RNA translocation on RNA-dependent RNA polymerase, providing insights for rational design of improved antiviral drugs.

MOLECULAR CELL (2021)

Review Microbiology

Coronavirus biology and replication: implications for SARS-CoV-2

Philip V'kovski et al.

Summary: This review discusses key aspects of coronavirus biology and their implications for SARS-CoV-2 infections, treatment, and prevention strategies. Understanding virus-host interactions at the molecular level is crucial for developing effective intervention strategies. Summarizing the discoveries of SARS-CoV-2 infection and comparing it with other coronaviruses will support future preparedness and combat strategies.

NATURE REVIEWS MICROBIOLOGY (2021)

Editorial Material Biotechnology & Applied Microbiology

Therapeutic options for the 2019 novel coronavirus (2019-nCoV)

Guangdi Li et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Article Multidisciplinary Sciences

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Structure of the RNA-dependent RNA polymerase from COVID-19 virus

Yan Gao et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

David E. Gordon et al.

NATURE (2020)

Article Multidisciplinary Sciences

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Zhenming Jin et al.

NATURE (2020)

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Biochemistry & Molecular Biology

SynergyFinder 2.0: visual analytics of multi-drug combination synergies

Aleksandr Ianevski et al.

NUCLEIC ACIDS RESEARCH (2020)

Article Pharmacology & Pharmacy

Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites

Ashleigh Shannon et al.

ANTIVIRAL RESEARCH (2020)

Editorial Material Multidisciplinary Sciences

How does SARS-CoV-2 cause COVID-19?

Nicholas J. Matheson et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Activation and evasion of type I interferon responses by SARS-CoV-2

Xiaobo Lei et al.

NATURE COMMUNICATIONS (2020)

Editorial Material Medicine, General & Internal

Therapy for Early COVID-19 A Critical Need

Peter S. Kim et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Multidisciplinary Sciences

Architecture of a SARS-CoV-2 mini replication and transcription complex

Liming Yan et al.

NATURE COMMUNICATIONS (2020)

Article Chemistry, Medicinal

Can Papain-like Protease Inhibitors Halt SARS-CoV-2 Replication?

Biplab K. Maiti

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)

Review Chemistry, Medicinal

Potential Therapeutic Agents and Associated Bioassay Data for COVID-19 and Related Human Coronavirus Infections

Qiongqiong Angela Zhou et al.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)

Article Biochemistry & Molecular Biology

CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells

Ke Wang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Biochemistry & Molecular Biology

Delicate structural coordination of the Severe Acute Respiratory Syndrome coronavirus Nsp13 upon ATP hydrolysis

Zhihui Jia et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Virology

Nucleoside analogues for the treatment of coronavirus infections

Andrea J. Pruijssers et al.

CURRENT OPINION IN VIROLOGY (2019)

Article Multidisciplinary Sciences

Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors

Robert N. Kirchdoerfer et al.

NATURE COMMUNICATIONS (2019)

Review Pharmacology & Pharmacy

Applying synergy metrics to combination screening data: agreements, disagreements and pitfalls

Anna H. C. Vlot et al.

DRUG DISCOVERY TODAY (2019)

Article Chemistry, Multidisciplinary

Using an Old Drug to Target a New Drug Site: Application of Disulfiram to Target the Zn-Site in HCV NS5A Protein

Yu -Ming Lee et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)

Article Multidisciplinary Sciences

Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex

Yuanyuan Ma et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Biochemistry & Molecular Biology

Coronavirus Nsp10, a Critical Co-factor for Activation of Multiple Replicative Enzymes

Mickael Bouvet et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Review Chemistry, Multidisciplinary

Factors Controlling the Role of Zn and Reactivity of Zn-bound Cysteines in Proteins: Application to Drug Target Discovery

Yu-Ming Lee et al.

JOURNAL OF THE CHINESE CHEMICAL SOCIETY (2014)

Article Biochemistry & Molecular Biology

Structure of a Zinc-binding Domain in the Junin Virus Envelope Glycoprotein

Klara Briknarova et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)